-
Je něco špatně v tomto záznamu ?
Protein τ-mediated effects on rat hippocampal choline transporters CHT1 and τ-amyloid β interactions [Protein tau-mediated effects on rat hippocampal choline transporters CHT1 and tau-amyloid beta interactions]
Z. Kristofikova, D. Ripova, K. Hegnerová, J. Sirova, J. Homola,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT11225
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2009-08-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- amyloidní beta-protein metabolismus MeSH
- hipokampus metabolismus MeSH
- krysa rodu rattus MeSH
- potkani Wistar MeSH
- povrchová plasmonová rezonance MeSH
- proteiny přenášející kationty metabolismus MeSH
- proteiny tau metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
It is suggested that intracellular tau protein (τ), when released extracellularly upon neuron degeneration, could evoke direct toxic effects on the cholinergic neurotransmitter system through muscarinic receptors and thus contribute to the pathogenesis of Alzheimer's disease. In this study, we evaluated the in vitro effects of six naturally occurring monomeric τ isoforms on rat hippocampal synaptosomal choline transporters CHT1 (large transmembrane proteins associated with high-affinity choline transport and vulnerable to actions of amyloid β peptides (Aβ) applied in vitro or in vivo). Some τ isoforms at nM concentrations inhibited choline transport in a dose- and time-dependent saturable manner (352 = 441 > 410 = 383 > 381 = 412) and effects were associated with changes in the Michaelis constant rather than in maximal velocity. Moreover, the actions of τ 352/441 were not influenced by previous depolarisation of synaptosomes or by previous depletion of membrane cholesterol. Specific binding of [3H]hemicholinium-3 was not significantly altered by τ 352/441 at higher nM concentrations. Results of in vitro tests on CHT1 transporters from cholesterol-depleted synaptosomes supported interactions between Aβ 1-40 and τ 352. In addition, we developed surface plasmon resonance biosensors to monitor complexes of Aβ 1-42 and τ 352 using a sandwich detection format. It seems, therefore, that protein τ, similar to Aβ peptides, can contribute to the pathogenesis of Alzheimer's disease through its actions on CHT1 transporters. However, the interaction mechanisms are quite different (τ probably exerts its effects through direct interactions of microtubule binding repeats with extracellular portions of the CHT1 protein without influencing the choline recognition site, Aβ rather through lipid rafts in the surrounding membranes). An N-terminal insert of τ is not necessary but the N-terminal projection domain plays a role. The developed biosensor will be used to detect Aβ-τ complexes in cerebrospinal fluid in order to evaluate them as prospective biomarkers of Alzheimer's disease.
Alzheimer Disease Centre Prague Psychiatric Centre Prague Czech Republic
Institute of Photonics and Electronics Academy of Sciences Prague Czech Republic
Protein tau-mediated effects on rat hippocampal choline transporters CHT1 and tau-amyloid beta interactions
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14050935
- 003
- CZ-PrNML
- 005
- 20150109135625.0
- 007
- ta
- 008
- 140401s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11064-013-1101-5 $2 doi
- 035 __
- $a (PubMed)23824558
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kristofikova, Zdena $u Alzheimer Disease Centre, Prague Psychiatric Centre, Prague, Czech Republic
- 245 10
- $a Protein τ-mediated effects on rat hippocampal choline transporters CHT1 and τ-amyloid β interactions / $c Z. Kristofikova, D. Ripova, K. Hegnerová, J. Sirova, J. Homola,
- 246 31
- $a Protein tau-mediated effects on rat hippocampal choline transporters CHT1 and tau-amyloid beta interactions
- 520 9_
- $a It is suggested that intracellular tau protein (τ), when released extracellularly upon neuron degeneration, could evoke direct toxic effects on the cholinergic neurotransmitter system through muscarinic receptors and thus contribute to the pathogenesis of Alzheimer's disease. In this study, we evaluated the in vitro effects of six naturally occurring monomeric τ isoforms on rat hippocampal synaptosomal choline transporters CHT1 (large transmembrane proteins associated with high-affinity choline transport and vulnerable to actions of amyloid β peptides (Aβ) applied in vitro or in vivo). Some τ isoforms at nM concentrations inhibited choline transport in a dose- and time-dependent saturable manner (352 = 441 > 410 = 383 > 381 = 412) and effects were associated with changes in the Michaelis constant rather than in maximal velocity. Moreover, the actions of τ 352/441 were not influenced by previous depolarisation of synaptosomes or by previous depletion of membrane cholesterol. Specific binding of [3H]hemicholinium-3 was not significantly altered by τ 352/441 at higher nM concentrations. Results of in vitro tests on CHT1 transporters from cholesterol-depleted synaptosomes supported interactions between Aβ 1-40 and τ 352. In addition, we developed surface plasmon resonance biosensors to monitor complexes of Aβ 1-42 and τ 352 using a sandwich detection format. It seems, therefore, that protein τ, similar to Aβ peptides, can contribute to the pathogenesis of Alzheimer's disease through its actions on CHT1 transporters. However, the interaction mechanisms are quite different (τ probably exerts its effects through direct interactions of microtubule binding repeats with extracellular portions of the CHT1 protein without influencing the choline recognition site, Aβ rather through lipid rafts in the surrounding membranes). An N-terminal insert of τ is not necessary but the N-terminal projection domain plays a role. The developed biosensor will be used to detect Aβ-τ complexes in cerebrospinal fluid in order to evaluate them as prospective biomarkers of Alzheimer's disease.
- 650 _2
- $a amyloidní beta-protein $x metabolismus $7 D016229
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a proteiny přenášející kationty $x metabolismus $7 D027682
- 650 _2
- $a hipokampus $x metabolismus $7 D006624
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a povrchová plasmonová rezonance $7 D020349
- 650 _2
- $a proteiny tau $x metabolismus $7 D016875
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ripova, Daniela $u Alzheimer Disease Centre, Prague Psychiatric Centre, Prague, Czech Republic
- 700 1_
- $a Hegnerová, Katerina $u Institute of Photonics and Electronics, Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Sirova, Jana $u Alzheimer Disease Centre, Prague Psychiatric Centre, Prague, Czech Republic
- 700 1_
- $a Homola, Jiri $u Institute of Photonics and Electronics, Academy of Sciences, Prague, Czech Republic
- 773 0_
- $w MED00003484 $t Neurochemical research $x 1573-6903 $g Roč. 38, č. 9 (2013), s. 1949-1959
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23824558 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140401 $b ABA008
- 991 __
- $a 20150109135803 $b ABA008
- 999 __
- $a ok $b bmc $g 1018071 $s 849515
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 38 $c 9 $d 1949-1959 $i 1573-6903 $m Neurochemical research $n Neurochem Res $x MED00003484
- GRA __
- $a NT11225 $p MZ0
- LZP __
- $a Pubmed-20140401